Radiotherapy for pituitary adenomas: an endocrinologist's perspective (Q41154083)

27 September 2017

1 reference

title

Radiotherapy for pituitary adenomas: an endocrinologist's perspective (English)

1 reference

27 September 2017

O'Halloran DJ

1

1 reference

27 September 2017

Shalet SM

series ordinal

2

1 reference

27 September 2017

publication date

1 January 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

8

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

79-84

1 reference

Diagnosis and management of pituitary tumours

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Pituitary prolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Primary radiotherapy of prolactinomas. Eight- to 15-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Conventional Supervoltage Irradiation Is an Effective Treatment for Acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Efficacy of Conventional Pituitary Irradiation in Acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Low-dose pituitary irradiation for acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Conventional radiation therapy in acromegaly. A review and reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Results of treating childhood Cushing's disease with pituitary irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Roentgen therapy in Cushing's syndrome without adrenocortical tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Results of treatment in 108 patients with Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Radiation-induced optic neuropathy: a magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Visual complications following irradiation for pituitary adenomas and craniopharyngiomas

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Progressive visual failure in acromegaly following external pituitary irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Treatment of acromegaly by external irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Brain stem necrosis after irradiation of pituitary adenoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Therapeutic irradiation and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

The long-term side effects of radiation therapy for benign brain tumors in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Radiation oncogenesis in relation to the treatment of pituitary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Treatment of chromophobe adenmas with megavoltage tirradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Hypopituitarism in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Hypopituitarism following pituitary irradiation for acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Treatment of prolactinomas with megavoltage radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Radiation-induced hypopituitarism is dose-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Long-term effect of 90Y pituitary implantation in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Pulsatile gonadotrophin-releasing hormone therapy in patients with pituitary tumours treated by surgery and irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Growth hormone replacement in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

Radiation and pituitary dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2896%2980111-7

7 January 2021

10.1016/S0936-6555(96)80111-7

Identifiers

DOI

1 reference

27 September 2017

1 reference